Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Surviving the cure: long term followup of hematopoietic cell transplant recipients

Bone Marrow Transplantation volume 48, pages 1145–1151 (2013)Cite this article

Subjects

Abstract

Advances in hematopoietic cell transplantation (HCT) have led to an increasing number of transplant survivors. However, long-term survival is challenged by late relapse, late complications and late non-relapse mortality, and HCT survivors need continued lifelong surveillance for screening, early detection and timely treatment of late complications such as secondary cancers, late infections and organ toxicity. Guidelines for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT were updated and published in 2012. However, several barriers to the care of HCT survivors and routine utilization of these guidelines in clinical practice exist. Examples include paucity of and challenges to conducting prospective randomized trials for screening and prevention of late complications, lack of resources to manage late effects at the level of transplant centers and community health care providers, and inadequate tools to facilitate care and followup of HCT survivors. We summarize the long-term followup guidelines in this review, discuss ways that providers can integrate and utilize them for the care of their patients, and identify areas for research that can inform and increase the utilization of screening and prevention guidelines in clinical practice.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant 2012; 47: 337–341.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012; 18: 348–371.

    PubMed  Google Scholar 

  3. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther 2012; 5: 1–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Gunasekaran U, Agarwal N, Jagasia MH, Jagasia SM . Endocrine complications in long-term survivors after allogeneic stem cell transplant. Semin Hematol 2012; 49: 66–72.

    Article  CAS  PubMed  Google Scholar 

  5. Williams KM, Chien JW, Gladwin MT, Pavletic SZ . Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA 2009; 302: 306–314.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Pidala J, Anasetti C, Jim H . Quality of life after allogeneic hematopoietic cell transplantation. Blood 2009; 114: 7–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Parsons SK, Phipps S, Sung L, Baker KS, Pulsipher MA, Ness KK . NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: health-related quality of life, functional, and neurocognitive outcomes. Biol Blood Marrow Transplant 2012; 18: 162–171.

    Article  PubMed  Google Scholar 

  8. Majhail NS . Secondary cancers following allogeneic haematopoietic cell transplantation in adults. Br J Haematol 2011; 154: 301–310.

    Article  PubMed  Google Scholar 

  9. McClune BL, Polgreen LE, Burmeister LA, Blaes AH, Mulrooney DA, Burns LJ et al. Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients. Bone Marrow Transplant 2011; 46: 1–9.

    Article  CAS  PubMed  Google Scholar 

  10. Tichelli A, Rovo A, Passweg J, Schwarze CP, Van Lint MT, Arat M et al. Late complications after hematopoietic stem cell transplantation. Expert rev hematol 2009; 2: 583–601.

    Article  PubMed  Google Scholar 

  11. Tichelli A, Bhatia S, Socie G . Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation. Br J Haematol 2008; 142: 11–26.

    Article  PubMed  Google Scholar 

  12. Savani BN, Griffith ML, Jagasia S, Lee SJ . How I treat late effects in adults after allogeneic stem cell transplantation. Blood 2011; 117: 3002–3009.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Majhail NS, Lazarus HM, Burns LJ . Iron overload in hematopoietic cell transplantation. Bone Marrow Transplant 2008; 41: 997–1003.

    Article  CAS  PubMed  Google Scholar 

  14. Abboud I, Peraldi MN, Hingorani S . Chronic kidney diseases in long-term survivors after allogeneic hematopoietic stem cell transplantation: monitoring and management guidelines. Semin Hematol 2012; 49: 73–82.

    Article  PubMed  Google Scholar 

  15. Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D et al. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol 2011; 29: 2230–2239.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT). Bone Marrow Transplant 2006; 37: 249–261.

    Article  CAS  PubMed  Google Scholar 

  17. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2006; 12: 138–151.

    Article  PubMed  Google Scholar 

  18. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant 2009; 44: 453–558.

    Article  CAS  PubMed  Google Scholar 

  19. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143–1238.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Pulsipher MA, Skinner R, McDonald GB, Hingorani S, Armenian SH, Cooke KR et al. National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines. Biol Blood Marrow Transplant 2012; 18: 334–347.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Care CoCSI, Life Qo, Medicine Io, Council NR . From Cancer Patient to Cancer Survivor: Lost in Transition. The National Academies Press, 2005.

    Google Scholar 

  22. Bhatia S, Robison LL, Francisco L, Carter A, Liu Y, Grant M et al. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood 2005; 105: 4215–4222.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ et al. Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma. Br J Haematol 2009; 147: 129–139.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ et al. High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR. Bone Marrow Transplant 2011; 46: 385–392.

    Article  CAS  PubMed  Google Scholar 

  25. Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 2007; 110: 3784–3792.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M et al. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase. J Clin Oncol 2010; 28: 1888–1895.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Nivison-Smith I, Simpson JM, Dodds AJ, Ma DD, Szer J, Bradstock KF . Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates. Biol Blood Marrow Transplant 2009; 15: 1323–1330.

    Article  PubMed  Google Scholar 

  28. Martin PJ, Counts GW, Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 2010; 28: 1011–1016.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge the time and effort contributed by the writing committee members who participated in the development of 2012 guidelines for ‘Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation’. Members included: Mahmoud Aljurf, Yoshiko Atsuta, Carmem Bonfim, Linda J Burns, Naeem Chaudhri, Stella Davies, Stephanie Lee, Shinichiro Okamoto, Adriana Seber, Gerard Socie, Jeff Szer, Maria Teresa Van Lint, Andre Tichelli and John Wingard.

Author information

Authors and Affiliations

  1. National Marrow Donor Program and Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA

    N S Majhail

  2. Medical College of Wisconsin and Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA

    J Douglas Rizzo

Authors
  1. N S Majhail
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Douglas Rizzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N S Majhail.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Majhail, N., Douglas Rizzo, J. Surviving the cure: long term followup of hematopoietic cell transplant recipients. Bone Marrow Transplant 48, 1145–1151 (2013). https://doi.org/10.1038/bmt.2012.258

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2012.258

Keywords

This article is cited by

Search

Advanced search

Quick links